
| ASSET | DATE | % RETURN |
|---|---|---|
Richtech Robotics Inc Class B Common Stock (RR) | 12/27/2023 - 1/22/2024 | 77.22% |
Real Brokerage (REAX) | 12/27/2023 - 1/22/2024 | 64.97% |
Alliance Entertainment Holding Corporation Class A Common Stock (AENT) | 12/27/2023 - 1/22/2024 | 55.56% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/22/2024 | 50.6% |
Here (HERE) | 12/27/2023 - 1/22/2024 | 50.6% |
SEALSQ (LAES) | 12/27/2023 - 1/22/2024 | 48.21% |
Neuropace (NPCE) | 12/27/2023 - 1/22/2024 | 47.22% |
Dianthus Therapeutics (DNTH) | 12/27/2023 - 1/22/2024 | 42.61% |
Yirendai (YRD) | 12/27/2023 - 1/22/2024 | 39.8% |
Sharplink Gaming (SBET) | 12/27/2023 - 1/22/2024 | 37.12% |
Keros Therapeutics (KROS) | 12/27/2023 - 1/22/2024 | 36.03% |
Ardelyx (ARDX) | 12/27/2023 - 1/22/2024 | 35.07% |
Abacus Life (ABL) | 12/27/2023 - 1/22/2024 | 35.01% |
ATAI Life Sciences (ATAI) | 12/27/2023 - 1/22/2024 | 33.82% |
American Public Education (APEI) | 12/27/2023 - 1/22/2024 | 33.82% |
Capital Clean Energy Carriers (CCEC) | 12/27/2023 - 1/22/2024 | 33.78% |
Akso Health Group ADR (AHG) | 12/27/2023 - 1/22/2024 | 33.68% |
Eightco (ORBS) | 12/27/2023 - 1/22/2024 | 32.65% |
Qilian International (BGM) | 12/27/2023 - 1/22/2024 | 32.08% |
Mereo BioPharma Group PLC ADR (MREO) | 12/27/2023 - 1/22/2024 | 30.52% |
Verastem (VSTM) | 12/27/2023 - 1/22/2024 | 28.85% |
Cullinan Oncology LLC (CGEM) | 12/27/2023 - 1/22/2024 | 28.2% |
Bright Minds Biosciences (DRUG) | 12/27/2023 - 1/22/2024 | 28% |
Solid Biosciences LLC (SLDB) | 12/27/2023 - 1/22/2024 | 26.77% |
Alvotech (ALVO) | 12/27/2023 - 1/22/2024 | 26.38% |